During the past decade, Keele Medical Place conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Keele Medical Place" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Eisai Inc." with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keele Medical Place" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Canadian Stroke Network" with 1 trials as a collaborator, "Canadian Stroke Prevention Intervention Network" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator and "Heart and Stroke Foundation of Canada" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Keele Medical Place" are "Atrial Fibrillation" (2 trials), "Active Ulcerative Colitis" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Cardiovascular Disease" (1 trials) and "High Cardiovascular Risk" (1 trials). Many other conditions were trialed in "Keele Medical Place" in a lesser frequency.

Most popular intervention types in "Keele Medical Place" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-ASA (5-Aminosalicylate)" (1 trials), "Ibuprofen" (1 trials), "Lorcaserin hydrochloride" (1 trials), "Naproxen" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Keele Medical Place" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Keele Medical Place". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Keele Medical Place, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Keele Medical Place, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".